scholarly article | Q13442814 |
P356 | DOI | 10.1080/09637480802498820 |
P698 | PubMed publication ID | 19212858 |
P2093 | author name string | C.A. Vallejo-Flores | |
J.N. Carrillo-Arcentales | |||
L.A. Zurita-Gavilanes | |||
M.A. Mestanza-Peralta | |||
M.M. Camacho-Zambrano | |||
P. Benito-Ruiz | |||
R.A. Villacís-Tamayo | |||
S.V. Vargas-López | |||
P2860 | cites work | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
Role of collagen hydrolysate in bone and joint disease | Q28143414 | ||
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial | Q32050561 | ||
Osteoarthritis: new insights. Part 1: the disease and its risk factors. | Q33921631 | ||
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 | ||
Osteoarthritis: new insights. Part 2: treatment approaches. | Q34080887 | ||
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. | Q34408410 | ||
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial | Q34470417 | ||
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator | Q34574562 | ||
Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature | Q34578142 | ||
Meta-analysis: chondroitin for osteoarthritis of the knee or hip. | Q34619761 | ||
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey | Q35549907 | ||
Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life. | Q35636850 | ||
Osteoarthritis: epidemiology | Q36399049 | ||
Consumption of a functional fermented milk containing collagen hydrolysate improves the concentration of collagen-specific amino acids in plasma | Q46426586 | ||
Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index | Q47418289 | ||
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. | Q53290466 | ||
P433 | issue | sup2 | |
P304 | page(s) | 99-113 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | International Journal of Food Sciences and Nutrition | Q15709523 |
P1476 | title | A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort | |
P478 | volume | 60 |
Q58329134 | Carbohydrate particles as protein carriers and scaffolds: physico-chemical characterization and collagen stability |
Q50890103 | Collagen hydrolysate inhibits zymosan-induced inflammation. |
Q28485134 | Collagen metabolism of human osteoarthritic articular cartilage as modulated by bovine collagen hydrolysates |
Q36123541 | Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial |
Q60045958 | Comparative Analysis of Peptide Composition and Bioactivity of Different Collagen Hydrolysate Batches on Human Osteoarthritic Synoviocytes |
Q42099673 | Determination of serum biomarkers in osteoarthritis patients: a previous interventional imaging study revisited |
Q58111164 | Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials |
Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
Q92441765 | Food-Derived Collagen Peptides, Prolyl-Hydroxyproline (Pro-Hyp), and Hydroxyprolyl-Glycine (Hyp-Gly) Enhance Growth of Primary Cultured Mouse Skin Fibroblast Using Fetal Bovine Serum Free from Hydroxyprolyl Peptide |
Q35807099 | Nutraceuticals for geriatrics |
Q38047227 | Nutraceuticals in the management of osteoarthritis : a critical review |
Q34146992 | Nutraceuticals: do they represent a new era in the management of osteoarthritis? – a narrative review from the lessons taken with five products |
Q37809746 | Pharmacologic therapy for osteoarthritis—the era of disease modification |
Q46622143 | Preparation and functional evaluation of collagen oligopeptide-rich hydrolysate from fish skin with the serine collagenolytic protease from Pseudoalteromonas sp. SM9913. |
Q64245298 | Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
Search more.